GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.

GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training. The network includes over 150 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.

GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

0
Network Investigators
0
Trained HQP
0
Funded Projects
0
Network Partners

Latest News

New GlycoNet Trainee Association Executive Committee announced

GlycoNet trainees will receive support to advance their professional development and promote their research activities.

The light at the end of the tunnel for heart failure

GlycoNet Investigators identified carbohydrate-derived molecules that may hold the key to preventing and treating the disease for which there is currently no cure.

Sweet science: Sugar research gets $20M stronger

GlycoNet’s Associate Director Clinical Partnerships, Dr. Lara Mahal, is bringing personalized health care to reality.

Quick Links

Upcoming Events

There are no upcoming events.

Network Members

© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.

en_USEnglish
fr_CAFrench en_USEnglish
Scroll to Top